Aptamers refer to short strands of nucleic acids or peptide molecules capable of forming secondary and tertiary structures. These molecules bind specifically to the cellular targets and are created by selecting randomly from the complex libraries of synthetic nucleic acids. These receptor molecules can be modified in order to enhance the stability and availability in biological environments. Aptamers possess potential applications in research, clinical, industrial and medical areas. Since the 1990s, aptamers have been tested for their clinical relevance. Aptamers are chemically equivalent to protein therapeutics and are highly specific, non-immunogenic and small in size.
Despite of its advantages over protein therapeutics, aptamers are not able to establish their strong presence in the market. According to a research study published in 2010, till date only one aptamer based drug has received regulatory approval. The first aptamer based therapeutic was indicated for the treatment of age related macular degeneration and was FDA approved in the year 2004. At present many other aptamer molecules are being evaluated in clinical trials.
Browse Report @:http://www.transparencymarketresearch.com/aptamers-market.html
Emergence of aptamer molecules in various diagnostic and therapeutic applications holds immense growth prospects in the near future. With the development of systematic evolution of ligands by exponential enrichment (SELEX) process, aptamers are replacing antibodies in both diagnostic and therapeutic applications. Aptamers market can be categorized on the basis of product type, applications and geographies. The application areas of aptamers include diagnostics, biosensors, drug discovery, bio-markers, therapeutics and others. The major product types of aptamers include nucleic acid and peptide aptamers.
High specificity, intensive research initiatives, wide application areas, technological advancement and heavy investments by manufacturers are some of the factors driving the growth of the global aptamers market. Less accessibility, low awareness, stringent governmental regulations and difficult commercialization of aptamer products are the major challenges prevalent in this market. Technological advances in the fields of targeted therapies, nanotechnology and medical imaging facilitate sustainable growth opportunities for aptamers market. In addition, rigorous research in pipeline creates the possibility of replacement of antibody therapies in the near future.
Browse Upcoming Reports @:http://www.transparencymarketresearch.com/latest.php?type=U
Aptamer Solutions, Ltd, Aptares AG, AM Biotechnologies LLC, OTC Biotech, Pfizer, Inc., Base Pair Biotechnologies, Trilink Biotechnologies, Inc. and Aptamer Sciences, Inc. are some of the leading players in the global aptamers market.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.